Guillermo Moreno Sanz

Abagune Research

Dr. Moreno-Sanz has authored 25+ scientific articles and 3 patents describing the role of the endocannabinoid system on pain perception. He holds degrees in Biochemistry and Organic chemistry from the University of Zaragoza, and obtained his PhD in Neurosciences from the Complutense University of Madrid in Spain. He gained broad international experience with long-term fellowships in the Netherlands, Italy and the US, where he has developed most of his career at the University of California, Irvine, working with Prof. Daniele Piomelli, where he discovered a new class of cannabinoid analgesics devoid of unwanted psychoactivity. He participated in the elaboration of the 2017 report “The Health Effects of Cannabis and Cannabinoids” by the National Academies of Sciences. He then relocated to Spain and founded Abagune Research, a privately-owned company that provides scientific advice, research solutions and product development services to regulators, disseminators and operators within the international cannabis industry.